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Abstract 26 
Objectives To evaluate if sensory, motor and psychological factors are different in severe 27 
lateral epicondylalgia compared to less severe cases and control.  28 
Methods 164 patients with unilateral lateral epicondylalgia and 62 healthy control 29 
participants of comparable age and sex underwent the following testing: quantitative sensory 30 
testing (pressure, thermal pain thresholds), pain-free grip, quality of life (EuroQol) and 31 
psychological (HADS, Tampa).  Cluster analysis classified patients into mild, moderate or 32 
severe subgroups using the Patient Rated Tennis Elbow Evaluation (PRTEE). Data were then 33 
evaluated to determine differences between control and lateral epicondylalgia subgroups. 34 
Results Bilateral cold hyperalgesia (affected elbow, standardised mean difference (SMD): 35 
1.14, P=0.000; unaffected elbow SMD: 0.94, P=0.000) and unilateral heat hyperalgesia 36 
(SMD -1.06, P=0.001) were evident in severe lateral epicondylalgia in comparison to healthy 37 
controls. All patient groups regardless of severity demonstrated bilateral and widespread 38 
mechanical hyperalgesia relative to controls (P<0.003), however only those with moderate 39 
and severe symptoms showed large differences (SMD>0.8) at all sites. Quality of life was 40 
significantly poorer in patients with severe symptoms, while anxiety, depression and 41 
kinesiophobia did not differ between subgroups. 42 
Discussion Lateral epicondylalgia patients presenting with severe pain and disability could 43 
be distinguished by hypersensitivity to thermal stimuli, notably bilateral cold hyperalgesia. 44 
Findings may implicate a combination of central, peripheral and sympathetic nervous system 45 
processes and may help explain the poorer outcomes found in this subpopulation. 46 
Keywords / Phrases: tennis elbow, hyperalgesia, depression, quality of life, kinesiophobia. 47 
  48 
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Introduction 49 
Lateral epicondylalgia (LE) or tennis elbow affects up to 3% of the population with peak 50 
incidence occurring between 40-50 years of age.1, 2 For the majority of sufferers, LE is self-51 
limiting, with an average duration of a typical episode between six months and two years.3  52 
However, in two recent randomised controlled trials, 10 and 17% of people adopting a wait-53 
and-see policy failed to report successful outcomes after one year.4, 5 Furthermore, it has been 54 
estimated that between 5 and 10% of patients develop chronic symptoms and eventually 55 
undergo surgery.6, 7 High pain and disability at baseline is one of the few consistently 56 
reported indicators of poorer long term outcome after conservative3, 8, 9 and surgical treatment 57 
of LE.10  For this reason, it might be valuable to identify other features that differentiate those 58 
individuals with higher pain and disability from those with lesser symptoms. 59 
 60 
The relative simplicity of the clinical presentation of LE belies the complexity of its 61 
underlying aetiological processes. The mechanisms of pain and disability are likely 62 
multifactorial, involving an interaction of local tendon pathophysiological changes, motor 63 
impairment, nociceptive system mechanisms11 and possibly psychological factors.12  Motor 64 
impairment is widespread in the affected upper limb,{Alizadehkhaiyat, 2007 #17}{Coombes, 65 
2011 #1344} with consistent evidence of markedly reduced pain-free grip strength being the 66 
strongest feature.24, 25 Nociceptive system impairments in LE as measured through 67 
quantitative sensory testing have identified sensory alterations, but little is known about the 68 
distinct patterns of these changes in those who have high levels of pain and disability. A 69 
number of studies have shown that bilateral mechanical hyperalgesia exists in LE,13-15 while a 70 
nascent body of research has explored thermal hyperalgesia.15-18  Recently Ruiz-Ruiz et al16 71 
reported bilateral thermal hyperalgesia in a group of 16 LE participants, whereas other 72 
authors19 have previously proposed that a subgroup of patients with severe LE exhibit cold 73 
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hyperalgesia. Cold hyperalgesia is emerging as an important factor in other musculoskeletal 74 
disorders such as whiplash associated disorders, with evidence that it can differentiate 75 
subgroups and help predict poor recovery over and above that of baseline pain and 76 
disability.20, 21 In addition, Huge et al identified bilateral cold and heat hyperalgesia in acute 77 
complex regional pain syndrome (CRPS), and incomplete recovery of cold pain thresholds in 78 
chronic CRPS in comparison to healthy controls.22 There is a growing interest in possible 79 
psychological factors being associated with chronic musculoskeletal conditions, for example, 80 
fear avoidance has been implicated.23 Preliminary evidence of higher levels of depression and 81 
anxiety, which was correlated with pain and disability, has been identified in a small study of 82 
LE (n=16), prompting a need for further evaluation of psychological factors in LE.  83 
 84 
The aim of this cross-sectional study was to identify whether sensory, motor and 85 
psychological factors can distinguish the subgroup of LE patients with higher pain and 86 
disability from those with lesser symptoms and a healthy control population.  Comprehensive 87 
analysis might provide novel insights into the pathophysiology of the disease and 88 
mechanisms underlying delayed recovery found in patients with high baseline pain.  89 
 90 
 91 
Methods 92 
 93 
Patients and control participants 94 
 95 
165 participants with LE meeting the following criteria for a randomised controlled trial26 96 
were recruited: unilateral elbow pain over the lateral epicondyle for longer than six weeks 97 
and aggravated by a combination of palpation, gripping and resisted wrist and/or finger 98 
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extension.  Participants were excluded if they had other upper limb conditions, such as, 99 
cervicogenic, radiohumeral or neurological, or experienced recent fractures, corticosteroid 100 
injection or physiotherapy treatment. 62 healthy participants between 35 and 70, with no 101 
history of LE were recruited such that the control group had a similar proportion of males and 102 
females to the overall LE population. Participants were excluded if they experienced 103 
concomitant neck or other arm pain that prevented participation in their usual work or 104 
recreational activities or necessitated treatment within the past six months.  All part icipants 105 
were recruited from the general community through media advertisements. Ethical approval 106 
was granted by the institutional review board and informed written consent was obtained 107 
from all participants. 108 
 109 
 110 
Measures 111 
 112 
Pressure pain threshold 113 
Pressure pain thresholds (PPT) were measured using a digital algometer (Somedic AB, 114 
Farsta, Sweden) with probe size of 1cm2, applied at a rate of 40 kPa/s until the first sensation 115 
of pain was perceived. PPT were measured bilaterally at the lateral epicondyle and C6-C7 116 
facet joints and over the left tibialis anterior muscle. These sites have been previously 117 
evaluated in LE, demonstrating substantial intra-rater repeatability (ICC>0.89).27  118 
 119 
Thermal pain thresholds 120 
Heat (HPT) and cold (CPT) pain thresholds were measured bilaterally over the lateral elbow 121 
using the Thermotest system (Somedic AB, Farsta, Sweden).17 Previous studies have 122 
confirmed the reliability of these measures (ICC>0.86).15  From a baseline temperature of 123 
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30°C, the thermode was increased or decreased at a rate of 1°C/s until the first sensation of 124 
pain was perceived, or until maximum and minimum cut-out temperatures of 50°C and 5°C 125 
were reached.  126 
 127 
Pain-free grip  128 
Pain-free grip (PFG) is well established as a highly reliable (ICC>.97) and convenient 129 
clinical assessment tool, which correlates more strongly with disability and perceived 130 
improvement than maximal grip strength in LE populations.28-30 It was measured using a 131 
digital grip dynamometer with variable handle position (MIE, Medical Research, UK). The 132 
participant was positioned in supine with the tested elbow in relaxed extension and forearm in 133 
pronation, such that the palm of the hand faced down on the plinth.26 They were instructed to 134 
squeeze the dynamometer handle at a consistent rate and to stop the instant pain was 135 
experienced.  136 
 137 
Pain, disability and quality of life 138 
The patient rated tennis elbow evaluation (PRTEE) was used to quantify pain and functional 139 
disability in LE.31 The PRTEE has been validated in a MRI-confirmed LE population and 140 
demonstrated good reliability and sensitivity to change.31 Responses were scored on 11-point 141 
Likert scales with pain and disability subscales contributing equally to the total score, ranging 142 
from 0 (no pain or functional disability) to 100 (worst imaginable pain with a very significant 143 
functional disability).31 Participants were asked to rate the level of pain currently experienced 144 
at rest and the worst level of pain experienced during the past week on 100mm visual 145 
analogue scales (VAS) with the following endpoints: no pain (0mm) and worst pain 146 
imaginable pain (100mm). Their level of function during the past week was also rated on a 147 
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100mm VAS with endpoints: no function (0mm) and full function (100mm). Substantial test-148 
retest reliability has been demonstrated for these two VAS measures (ICC 0.89, 0.85).32 149 
 150 
The EuroQol EQ-5D instrument was used to measure health-related quality of life.33  151 
Responses to five questions regarding different health dimensions were used to generate an 152 
index, ranging from 0 to 1, with 1 representing perfect health, by applying predefined scoring 153 
weights.34 154 
 155 
Psychological factors  156 
The Hospital Anxiety and Depression Scale (HADS) was measured in all participants to 157 
quantify the two most common forms of psychological disturbances - anxiety and 158 
depression.35 It comprised questions rated on four point scales, with anxiety and depression 159 
subscales contributing equally to the total score, ranging from 0 to 42, with greater scores 160 
indicating greater anxiety and depression. The degree of kinesiophobia, also known as fear of 161 
movement or injury,36 was assessed in the LE participants with the shortened Tampa Scale 162 
for Kinesiophobia (TSK-11). Each of the 11 items were scored on four point Likert scales 163 
giving a total score ranging from 11 to 44, with higher scores indicating greater 164 
kinesiophobia.  165 
 166 
Procedure 167 
 168 
Following completion of relevant questionnaires, testing was performed in the following 169 
sequence: PFG, PPT, HPT, CPT. The same examiner (BKC) performed all tests, without 170 
knowledge of PRTEE total scores or clustering. Tests were performed in triplicate starting on 171 
the unaffected or left side in LE or control participants respectively, with twenty second 172 
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intervals. Mean values were used in analyses. In order to determine the reliability of 173 
quantitative sensory testing, they were measured twice in the first 46 participants with LE, 174 
separated by a one week interval in which their condition was assumed to be stable.  175 
 176 
 177 
Statistical analysis 178 
 179 
Cluster analysis (based on the K-means algorithm) of the PRTEE scores was performed using 180 
SPSS 19 (IBM, Somers, New York, USA) to classify LE participants into three subgroups. 181 
This procedure, previously used in studies of other musculoskeletal conditions (e.g., whiplash 182 
associated disorders37) attempts to identify homogenous groups of cases based on selected 183 
characteristics. Following the formation of clusters, analysis of variance (ANOVA) was 184 
performed for each continuous outcome in order to compare the three LE groups and the 185 
control group. To account for any potential influence of hand dominance, the control group 186 
was  randomly  allocated  a  “matched  affected  arm”  with an equivalent proportion of dominant 187 
sided arms as that observed in the LE group.38, 39  Sex (between-subject) and Side (within-188 
subject) factors were included in the ANOVA model along with Group (between-subject). 189 
Where significant side by group interactions were present, follow-up univariate ANOVA was 190 
performed separately for affected and unaffected sides. Pairwise comparisons of interest 191 
(simple effects) were followed up with Bonferroni post-hoc tests. Significance was 192 
nominated a-priori at P<0.01. To enable comparison of effect sizes, standardised mean 193 
differences (SMD) were calculated by dividing mean differences (MD) relative to the control 194 
group (extracted from SPSS ) by the pooled standard deviation (SD). SMD scores greater 195 
than 0.8 were interpreted as a strong effect.40 Categorical outcomes were compared between 196 
groups using Chi-squared analysis. Intra-class correlation coefficients (ICC) and their 95% 197 
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confidence intervals (CI) were calculated using an ICC(3,1) model as a measure of test-retest 198 
reliability. 199 
 200 
Results 201 
Analysis was performed using data from 62 healthy controls and 164/165 patients with LE, 202 
owing to one missing PRTEE questionnaire. Cluster analysis identified three subgroups 203 
within the LE population based on total PRTEE scores (Figure 1). The clusters, referred to 204 
herein as mild, moderate and severe LE, showed an expected incremental increase in mean 205 
total PRTEE, supported by a similar increase in worst/resting pain and decrease in function as 206 
measured using VAS (P<0.01). Injury duration was not found to differ between LE 207 
subgroups, with the average duration being 25 weeks (range six weeks to four years). Levels 208 
of anxiety, depression and kinesiophobia were also not significantly different between LE 209 
subgroups. No other demographic differences were found between LE and control groups, 210 
including gender, age, body mass index, manual occupation or participation in sports 211 
involving gripping.  212 
The severe LE cluster contained the smallest number of patients (n=27), of which 59.3% 213 
were female. These patients were characterised by substantial worst pain levels (mean ± SD: 214 
78.1 ± 16.2) and notable resting pain levels (21.8mm ± 12.5mm). Their health-related quality 215 
of life (0.59 ± 0.16) was significantly poorer, and the majority (66.7%) reported sleep 216 
disturbances due to their elbow condition. The mild LE cluster (n=53) contained a smaller 217 
proportion (28.3%) of females and was characterised by moderate worst pain levels (50.6 ± 218 
18.2), minimal pain at rest (6.5 ± 13.8mm), higher quality of life (0.77 ± 0.15) and lower 219 
prevalence (32.1%) of sleep disturbance, though the latter was not statistically different to the 220 
severe group (P = 0.011). The moderate LE cluster comprised the largest number of patients 221 
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(n=84), displaying intermediary characteristics for pain, quality of life and other clinical 222 
variables (Table 1). 223 
Substantial test-retest reliability (ICC>0.80)41 was found for all quantitative sensory measures 224 
over a one week period (PPT elbow 0.80, PPT neck 0.84, PPT tibia 0.83, HPT 0.86, CPT 225 
0.84). Moderate (ICC 0.79) and substantial (ICC 0.89) reliability was found for PFG testing 226 
of the affected and unaffected arms respectively.  227 
Thermal pain threshold 228 
Analysis of pain thresholds to cold stimuli revealed significant main effects for both side 229 
(P<0.001) and group (P=0.002) but no interaction effect (P=0.195) (Figure 2). Post hoc 230 
analysis revealed only the severe LE group demonstrated significantly reduced thresholds to 231 
cold pain compared to controls, evident at both the affected (MD 6.7⁰C, 99% CI 1.6 to 232 
11.8⁰C, P<0.001, SMD 1.14) and unaffected elbow (MD 4.4⁰C, 99% CI 0.3 to 8.5⁰C, 233 
P=0.004, SMD 0.94).  234 
Pain thresholds to heat stimuli demonstrated a significant interaction between side and group 235 
(P=0.005). No differences were found for the unaffected elbow between controls and any of 236 
the LE groups (P=0.172). In contrast, significant differences were found between groups for 237 
the affected elbow (P=0.004) (Figure 2). Post-hoc analysis revealed only the severe LE group 238 
demonstrated significantly lower HPT on the affected side in comparison to controls (MD -239 
3.0⁰C, 99% CI -0.5 to -5.5⁰C, SMD -1.06).  240 
Pressure pain threshold  241 
A significant interaction between side and group was found for PPT at the elbow (P<0.001). 242 
All three LE groups demonstrated significantly lower thresholds in comparison to controls 243 
(P<0.01), with differences being greater on the affected (MD -251.5KPa, 99% CI -302.1,-244 
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200.8, SMD -1.92, P<0.001) than unaffected elbow (MD -131.4KPa, 99% CI -184.0,-78.8, 245 
SMD -0.97, P<0.001) (Figure 3). In the affected arm, progressively lower thresholds were 246 
seen with increasing pain and disability, with the differences between the severe and mild LE 247 
subgroups being statistically significant (P=0.005). PPT at the neck was significantly lower 248 
than controls, for all LE groups (MD -114.4kPa, 99% CI -163.8,-64.9, SMD -0.90, P<0.001).  249 
Similarly, PPT at the remote tibial site was significantly lower than controls for all LE groups 250 
(MD -102.6kPa, 99% CI -158.1,-47.1, SMD -0.84, P<0.001). There were no differences 251 
between mild, moderate and severe LE groups for PPT at either the neck or tibia 252 
Pain-free grip 253 
A significant three-way interaction between side, group and gender was evident for PFG 254 
(P<0.001). The affected arm of all three LE groups was significantly weaker than controls 255 
(P<0.001) (Figure 4). Differences were significantly (P<0.001) greater in males (MD -303N, 256 
99% CI -334.3,-271.7, SMD -5.00) than females (MD -177.1N, 99% CI -198.9,-155.4, SMD 257 
-4.85), but proportionally (MD/control mean) they were similar (males 75.6% and females 258 
73.4%), which is largely a function of greater normal strength in males.42 Analysis of the 259 
unaffected arm, revealed no differences between controls and any of the LE groups for either 260 
gender. 261 
Discussion 262 
LE patients could be clustered into subgroups according to self-rated levels of pain and 263 
disability, supported by incremental differences in corresponding pain and function VAS 264 
measures. This study is the first to show that the presence of thermal hyperalgesia in 265 
comparison to healthy controls is a distinguishing feature in LE patients with severe pain and 266 
disability. Specifically, hyperalgesia to both hot and cold were demonstrated at the affected 267 
elbow, while cold hyperalgesia was also evident at the unaffected elbow. Previous 268 
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investigation of the thermal sensory profile of LE has revealed inconsistent findings, ranging 269 
from bilateral deficits in HPT,16 to no differences in HPT,17, 43 or reduction of HPT in the area 270 
of pain referral.18  Elevated CPT was found in patients with unilateral LE compared to the 271 
unaffected arm17 and to healthy controls,15, 16 however only in the most recent study by Ruiz-272 
Ruiz et al were the differences statistically significant. It is highly likely that these studies 273 
were either underpowered (the largest number of LE patients examined was 16) or did not 274 
comprise sufficient numbers of patients with severe LE.  Our findings confirm the suspicions 275 
of Smith and colleagues that cold hyperalgesia exists in a subgroup of patients with LE.19  276 
 277 
The presence of thermal hyperalgesia in severe cases of LE might provide an insight into the 278 
possible underlying neurophysiological basis of a condition understood to be musculoskeletal 279 
in nature. That cold hyperalgesia was bilaterally present in severe cases of unilateral LE lends 280 
support to a central mechanism being involved in these cases.13-15, 44 Interestingly, there are 281 
similarities with CRPS 1 of the upper limb, where cold hyperalgesia has been associated with 282 
both peripheral sensitisation of C-fibres and central disinhibition of nociceptive pathways 283 
secondary to A-delta fibre degeneration.22 Others19 have proposed that cold hyperalgesia in 284 
LE may be dependent upon a sympathetic noradrenergic mechanism, based on their findings 285 
of selective improvement in CPT following guanethedine but not a control block in LE 286 
patients. They postulated that the presence of cold hyperalgesia may be a useful clinical 287 
indicator of the likely benefit of a sympathetic block, however this requires further research. 288 
It is becoming clear that to reconcile such findings from different studies requires further 289 
research.  290 
 291 
Apart from the likely central implications of bilateral cold hyperalgesia, the finding of heat 292 
hyperalgesia further adds to our understanding of the local neurophysiological mechanisms in 293 
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LE. Heat hyperalgesia has been linked with peripheral sensitisation of C-fibres.45 Peripheral 294 
sensitisation commonly occurs when nociceptors are exposed to inflammation or damaged 295 
tissue, however other changes in the immediate tissue environment, including the 296 
concentration of neurotransmitters, growth factors, hormones and neuropeptides, can act on 297 
the nociceptors.46 Histological evidence suggests LE is characterised by an absence of 298 
inflammatory mediators but high local concentrations of the excitatory neurotransmitter 299 
glutamate47 and presence of neuropeptides, Substance P and CGRP, at the origin of extensor 300 
carpi radialis brevis.48  It is tempting to speculate that in LE where there is likely no ongoing 301 
tissue inflammation, the observed heat sensitivity might reflect centrally driven neurogenic 302 
inflammation, for which Substance P and CGRP have been implicated. 303 
 304 
Health-related quality of life in our LE population was comparable to a previous study by 305 
Struijs et al.49 Notably, patients with severe LE demonstrated significantly poorer quality of 306 
life than those with lower pain and disability.   In addition, sleep disturbance was present in 307 
the majority (66.7%) of patients with severe LE, while only 32.1% of those with mild LE, 308 
however our study may have been underpowered to detect an effect on sleep. Sleep 309 
disturbance is increasingly recognised as a common symptom in chronic pain and may be 310 
associated with a number of negative physical and psychological effects, including lowered 311 
PPT and depression.50  312 
 313 
In agreement with previous research,13, 15, 51 mechanical hyperalgesia was found in the LE 314 
population at all evaluated sites and across all levels of pain and disability. A similar pattern 315 
of clinical presentation, involving spread of pain sensitivity to areas with no demonstrable 316 
pathology, is found in other musculoskeletal conditions and is thought to reflect a 317 
commonality of central sensitisation to their pathophysiology.45  In comparison to controls, 318 
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large differences (SMD>0.8) were only evident at the symptomatic elbow in the mild LE 319 
group, while moderate and severe LE groups displayed large differences at all evaluated sites. 320 
This suggests that the transition from local to widespread hyperalgesia may be associated 321 
with increased severity (i.e., greater levels of pain and disability).  322 
 323 
Investigation of the role of psychological factors in patients with LE has received limited 324 
attention. We found no difference in levels of anxiety and depression between LE groups or 325 
controls, which contrasts to the findings of Alizadehkhaiyat et al (2007), which reported 326 
significantly higher levels in 16 patients with LE compared to controls.12 Interestingly, our 327 
HADS scores were much lower, even in the most severe LE group, despite displaying 328 
comparable levels of pain and disability. Varied inclusion criteria (patients with a minimum 329 
three month duration of LE were recruited from an orthopaedic upper limb clinic) may 330 
potentially account for study differences. Likewise, we did not detect any difference in fear of 331 
movement between different levels of severity of LE. Our data lead us to postulate that levels 332 
of anxiety, depression and fear of movement are relatively less important features that 333 
distinguish severe from non-severe LE than are thermal hyperalgesia, quality of life and sleep 334 
disturbances.  335 
 336 
This cross-sectional study of 164 patients with LE and 62 healthy controls provides valuable 337 
groundwork toward understanding the relationships of sensory, motor and psychological 338 
factors  to  an  individual’s  pain  and  disability.  However,  there  are  some  caveats  and  limitations  339 
that the reader needs to consider. First, the cross-sectional design limits any inferences 340 
regarding causal relationships between the various factors, and longitudinal studies are 341 
needed to assess their therapeutic and prognostic implications. Second, results may not be 342 
generalised to LE patients who have other concomitant musculoskeletal disorders.  Third, 343 
15 
 
potential bias cannot be discounted, as the examiner was not blind to the control group, 344 
however the examiner was not aware of PRTEE clustered subgroups. Finally, multiple 345 
comparisons were conducted, a danger of which is finding statistically significant differences 346 
by chance. To reduce this possibility we set an a-priori p value of 0.01. Of further note, the 347 
proportion of females in the severe group was twice that of the mild LE group. Whilst not 348 
statistically significant, the potential influence of gender on observed findings cannot be fully 349 
ruled out.  350 
 351 
In conclusion, this study provides evidence of thermal hyperalgesia in patients with severe 352 
LE in comparison to healthy controls. It lends support to LE representing a complex 353 
pathophysiology involving peripheral sensitisation, central sensitisation and sympathetic 354 
mechanisms. Improved understanding of these physiological mechanisms may provide 355 
insight into why patients with higher initial pain demonstrate a poorer long term outcome. 356 
Further study is needed to identify optimal treatment strategies for the subgroup of patients 357 
with severe symptoms to improve pain, disability and quality of life outcomes. 358 
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Table Captions 489 
Table 1: Demographic and clinical characteristics for the control group and lateral 490 
epicondylalgia clusters based on pain and disability scores. 491 
Footnote: 492 
Results are expressed as mean ± standard deviation or count (%). Significant (P<0.01) 493 
differences between mild-moderate1, mild-severe2 and moderate-severe3 groups. PRTEE 494 
Patient Rated Tennis Elbow Evaluation (pain and disability); VAS visual analogue scale 495 
(mm); EQ-5D EuroQol (Health-related Quality of Life); TSK-11 Tampa Scale of 496 
Kinesiophobia; HADS Hospital Anxiety and Depression Scale. 497 
 498 
 499 
Table 2: Quantitative sensory and grip force tests for control group and lateral epicondylalgia 500 
clusters based on pain and disability scores.  501 
Footnote: 502 
Results are expressed as mean and standard deviations (SD) for affected (AFF) and 503 
unaffected (UN) sides as estimated by repeated measures ANOVA adjusting for gender.  504 
*Significantly (P<0.01) different to control group. Standardised mean differences (SMD) 505 
were estimated by dividing mean differences from controls by the pooled SD. Positive SMD 506 
represent  increased  sensitivity  in  the  LE  group.  †SMD  of  large  effect  size  (>0.8)..  CPT  Cold  507 
pain threshold (⁰C); HPT Heat pain threshold (⁰C); PPT Pressure pain threshold (Kpa); PFG 508 
Pain-free grip (N). 509 
 510 
  511 
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Figure Captions 512 
Figure 1. Lateral epicondylalgia (LE) clusters based on Patient Rated Tennis Elbow 513 
Evaluation (PRTEE) total scores. The box around the mean scores represents their standard 514 
deviations, while the whiskers refer to minimum and maximum scores. 515 
Figure 2:  Mean differences in heat pain thresholds (HPT, ⁰C) and cold pain thresholds 516 
(CPT, ⁰C) and 99% confidence intervals (CI) for lateral epicondylalgia (LE) clusters 517 
compared to the control group. Negative values represent increased sensitivity to heat and 518 
cold. 519 
Figure 3:  Mean differences in pressure pain thresholds (Kpa) and 99% confidence intervals 520 
(CI) for lateral epicondylalgia (LE) clusters compared to control group at each site (elbow, 521 
neck, tibia). 522 
Figure 4:  Mean differences in pain-free grip (N) and 99% confidence intervals (CI) for 523 
lateral epicondylalgia (LE) clusters compared to control group.  524 
 525 
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Table 1: Demographic and clinical characteristics for the control group and lateral 
epicondylalgia clusters based on pain and disability scores. 
 
  
Control  
n=62 
Lateral Epicondylalgia 
Sig  
<0.01   
All 
n=164 
Mild 
n=53 
Moderate  
n=84 
Severe 
n=27 
Age (years) 49.6 ± 8.7 49.6 ± 9.0 50.4 ± 9.5 48.8 ± 9.2 51.4 ± 8.8   
Female 28 (45.2) 63 (38.4) 15 (28.3) 32 (38.1) 16 (59.3)   
Post-menopausal  14 (50) 24 (38.1) 5 (33.3) 10 (31.3) 9 (56.3)   
Body mass index 25.4 ± 4.7 26.5 ± 5.1 26.1 ± 5.1 26.3 ± 4.6 27.1 ± 4.7   
Manual occupation  12 (19.4) 41 (24.8) 11 (20.8) 24 (28.6) 6 (22.2)   
Gripping sport 14 (22.6) 58 (35.2) 18 (34.0) 31 (36.9) 9 (33.3)   
Duration (weeks)  - 24.8 ± 30.8 26.6 ± 32.8 19.7 ± 30.2 32.3 ± 30.1   
PRTEE - 40.1 ± 14.1 24.0 ± 6.0 42.0 ± 5.2 62.6 ± 5.7 
1,2,3 
Resting pain (VAS) - 11.0 ± 14.1 6.5 ± 13.8 10.9 ± 12.8 21.8 ± 12.5 
2,3 
Worst pain (VAS) - 61.9 ± 19.3 50.6 ± 18.2 62.4 ± 16.5 78.1 ± 16.2 
1,2,3 
Function (VAS) - 68.6 ± 21.8 80.9 ± 21.1 65.8 ± 20.2 58.9 ± 20.3 
1,3 
EQ-5D - 0.74 ± 0.10 0.77 ± 0.15 0.74 ± 0.09 0.59 ± 0.16 
2,3 
Sleep disturbance  - 75 (45.5) 17 (32.1) 39 (46.4) 18 (66.7) 
  
TSK-11 - 24.3 ± 5.1 23.4 ± 5.1 24.5 ± 4.6 25.1 ± 4.7 
  
HADS 6.4 ± 3.9 6.5 ± 3.9 6.1 ± 4.4 6.5 ± 4.6 7.5 ± 4.2 
  
 
Results are expressed as mean ± standard deviation or count (%). Significant (P<0.01) 
differences between mild-moderate1, mild-severe2 and moderate-severe3 groups. PRTEE 
Patient Rated Tennis Elbow Evaluation (pain and disability); VAS visual analogue scale 
(mm); EQ-5D EuroQol (Health-related Quality of Life); TSK-11 Tampa Scale of 
Kinesiophobia; HADS Hospital Anxiety and Depression Scale. 
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Table 2: Quantitative sensory and grip force tests for control group and lateral epicondylalgia 
clusters based on pain and disability scores. 
Variable 
  
Control 
n=62 
Lateral Epicondylalgia 
Side 
All 
n=164 
Mild 
n=53 
Moderate 
n=84 
Severe 
n=27 
  mean ± SD   mean ± SD SMD mean ± SD SMD mean ± SD SMD 
CPT AFF 7.6 ± 6.1 11.8 ± 6.4 10.6 ± 6.6 0.52 11.4 ± 6.4 0.60 13.7 ± 5.7 * 1.12  † 
UN 7.1 ± 4.6 10.2 ± 5.1 8.9 ± 5.1 0.37 10.3 ± 4.6 0.59 11.2 ± 4.7 * 0.95  † 
HPT AFF 44.5 ± 3.1 42.6 ± 3.1 43.3 ± 2.9 0.31 42.5 ± 2.7 0.65 41.8 ± 3.1 * 1.03  † 
UN 44.3 ± 2.5 43.2 ± 2.82 43.6 ± 2.9 0.13 43.0 ± 2.7 0.43 43.2 ± 2.6 0.51 
PPT Elbow AFF 513.3 ± 128.3 261.1 ± 139.6 305 ± 141.2 * 1.52  † 246.6 ± 131.1 * 2.06  † 227.1 ± 129.9 * 2.32  † 
UN 499.5 ± 135.4 367.5 ± 130.6 382 ± 149.2 * 0.76 354.2 ± 138.4 * 1.03  † 394.7 ± 136.7 * 0.91  † 
PPT Neck AFF 403.8 ± 127.6 282.1 ± 134.5 294.2 ± 140.5 * 0.77 271.6 ± 130.1 * 0.98  † 300.3 ± 128.9 * 0.93  † 
UN 396.2 ± 133.1 287.6 ± 130.6 295.1 ± 147.1 * 0.65 277.3 ± 136.6 * 0.83  † 310.9 ± 135.1 * 0.75 
PPT Tibia Left 517.6 ± 130.7 407.4 ± 133.2 401.2 ± 144.1 * 0.76 405.9 ± 133.8 * 0.82  † 438.7 ± 132.0 * 0.80  † 
PFG Males AFF 400.6 ± 81.9 97.4 ± 79.4 109.9 ± 71.3 * 3.80  † 90.8 ± 77.0 * 3.90  † 85.6 ± 94.6 * 3.45  † 
UN 387.5 ± 99.2 367.6 ± 90.9 366.5 ± 86.6 0.22 369.4 ± 93.5  0.19 354.4 ± 114.8 0.30 
PFG 
Females 
AFF 241.3 ± 52.8 64.2 ± 62.8 84 ± 66.2 * 2.60  † 62.4 ± 56.8 * 3.29  † 49.3 ± 45.7 * 3.99  † 
UN 226.4 ± 62.2 206.5 ± 66.6 223.2 ± 78.6 0.04 209.5 ± 67.8 0.26 184.9 ± 54.6 0.73 
 
Results are expressed as mean and standard deviations (SD) for affected (AFF) and 
unaffected (UN) sides as estimated by repeated measures ANOVA adjusting for gender.  
*Significantly (P<0.01) different to control group. Standardised mean differences (SMD) 
were estimated by dividing mean differences from controls by the pooled SD. Positive SMD 
represent increased sensitivity in the LE group. †SMD  of  large  effect  size  (>0.8).. CPT Cold 
pain threshold (⁰C); HPT Heat pain threshold (⁰C); PPT Pressure pain threshold (Kpa); PFG 
Pain-free grip (N). 
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